CDX2 and neoplasm: Taken together, the noted signaling differences and lack of progression to adenocarcinoma in CDX2;APC;PID mice suggests that Group I Pak kinase activity is a key factor in tumorigenesis and the expression of PID peptide is sufficient to impede tumor progression in this CRC mouse model.